HZNP [NASD]
Horizon Therapeutics Public Limited Company
Index- P/E25.98 EPS (ttm)3.65 Insider Own0.40% Shs Outstand229.09M Perf Week4.97%
Market Cap21.56B Forward P/E13.23 EPS next Y7.17 Insider Trans-55.33% Shs Float225.83M Perf Month-7.22%
Income862.10M PEG1.95 EPS next Q1.36 Inst Own96.50% Short Float3.26% Perf Quarter4.03%
Sales3.77B P/S5.72 EPS this Y25.30% Inst Trans5.59% Short Ratio3.97 Perf Half Y-9.24%
Book/sh21.03 P/B4.51 EPS next Y20.65% ROA10.10% Target Price140.73 Perf Year3.47%
Cash/sh7.23 P/C13.12 EPS next 5Y13.30% ROE19.10% 52W Range82.51 - 120.54 Perf YTD-11.99%
Dividend- P/FCF18.23 EPS past 5Y33.30% ROI8.50% 52W High-21.32% Beta1.14
Dividend %- Quick Ratio3.30 Sales past 5Y26.90% Gross Margin75.90% 52W Low14.94% ATR3.89
Employees1940 Current Ratio3.60 Sales Q/Q158.50% Oper. Margin23.80% RSI (14)51.53 Volatility3.42% 4.50%
OptionableYes Debt/Eq0.53 EPS Q/Q257.10% Profit Margin22.90% Rel Volume1.14 Prev Close90.59
ShortableYes LT Debt/Eq0.53 EarningsMay 04 BMO Payout0.00% Avg Volume1.85M Price94.84
Recom1.60 SMA204.73% SMA50-6.77% SMA200-8.38% Volume2,100,370 Change4.69%
May-23-22Initiated SVB Leerink Mkt Perform $95
Mar-15-22Initiated Oppenheimer Outperform $140
Dec-08-21Initiated Wells Fargo Overweight $137
Nov-19-21Upgrade Goldman Neutral → Buy $168
Oct-07-21Resumed Jefferies Buy $132
Mar-22-21Resumed Morgan Stanley Overweight $103
Mar-12-21Initiated Wolfe Research Outperform $107
Sep-09-20Initiated JP Morgan Overweight $110
Aug-27-20Initiated Citigroup Buy $112
Jan-08-20Initiated Goldman Neutral $35
Sep-26-19Initiated BofA/Merrill Buy $34
Sep-12-19Initiated Guggenheim Buy
Aug-14-19Upgrade BMO Capital Markets Market Perform → Outperform $29 → $36
May-01-19Upgrade Citigroup Neutral → Buy $21 → $32
Mar-08-19Upgrade Morgan Stanley Equal-Weight → Overweight $32
Nov-15-18Downgrade Mizuho Buy → Neutral
Jun-27-18Downgrade Citigroup Buy → Neutral
Jan-12-18Upgrade Mizuho Neutral → Buy $12 → $18
Sep-28-17Initiated Goldman Buy $16
Jun-16-17Initiated Cantor Fitzgerald Overweight $13
May-24-22 08:00AM  
May-17-22 08:00AM  
May-16-22 09:00AM  
May-11-22 09:02AM  
08:30AM  
May-09-22 04:44PM  
May-07-22 08:08AM  
May-04-22 07:00AM  
May-03-22 11:40AM  
09:40AM  
09:15AM  
May-02-22 04:05PM  
01:00AM  
Apr-27-22 08:01AM  
Apr-19-22 09:00AM  
Apr-18-22 01:12PM  
Apr-14-22 08:00AM  
Apr-11-22 09:20AM  
Mar-31-22 08:30AM  
Mar-24-22 04:00AM  
Mar-21-22 02:51PM  
Mar-18-22 09:16AM  
09:02AM  
Mar-07-22 08:00AM  
Mar-04-22 08:48AM  
Mar-02-22 08:00AM  
Mar-01-22 07:00AM  
Feb-28-22 11:29AM  
Feb-23-22 08:00AM  
Feb-21-22 04:05PM  
Feb-16-22 08:15AM  
08:00AM  
Feb-15-22 11:00AM  
09:00AM  
Feb-10-22 08:00AM  
Feb-07-22 06:38PM  
08:00AM  
Feb-04-22 01:38PM  
Feb-02-22 05:38PM  
05:38PM  
11:10AM  
Jan-24-22 08:00AM  
Jan-19-22 09:38AM  
Jan-18-22 06:35AM  
Jan-11-22 07:45AM  
Jan-10-22 07:30AM  
Jan-07-22 08:20AM  
Jan-06-22 08:00AM  
Dec-23-21 08:00AM  
Dec-20-21 01:34PM  
Dec-16-21 08:00AM  
Dec-08-21 06:38PM  
Dec-07-21 02:30PM  
Dec-02-21 09:00AM  
08:30AM  
Dec-01-21 01:30AM  
Nov-22-21 10:13AM  
08:00AM  
Nov-19-21 07:28AM  
Nov-15-21 09:00AM  
Nov-12-21 08:33AM  
07:29AM  
Nov-09-21 08:00AM  
Nov-08-21 04:05PM  
Nov-07-21 12:57PM  
Nov-05-21 09:01AM  
Nov-04-21 01:00PM  
Nov-03-21 05:00PM  
12:55PM  
07:02AM  
07:00AM  
Nov-02-21 10:00AM  
Nov-01-21 11:05AM  
10:00AM  
Oct-27-21 08:30AM  
Oct-25-21 08:00AM  
Oct-22-21 09:29AM  
Oct-21-21 12:00PM  
Oct-15-21 08:49AM  
Oct-13-21 08:00AM  
Oct-12-21 09:00AM  
Oct-11-21 09:00AM  
08:30AM  
08:00AM  
Oct-06-21 08:00AM  
Oct-04-21 08:30AM  
08:00AM  
Sep-29-21 07:00AM  
Sep-28-21 09:14AM  
Sep-23-21 09:00AM  
08:30AM  
Sep-21-21 08:00AM  
07:30AM  
Sep-16-21 09:00AM  
Sep-07-21 08:30AM  
Sep-06-21 07:55AM  
Sep-01-21 09:10AM  
Aug-31-21 01:25PM  
Aug-23-21 04:01PM  
Aug-04-21 07:00AM  
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-trbw) for intravenous infusion; KRYSTEXXA (pegloticase injection) for intravenous infusion; RAVICTI (glycerol phenylbutyrate) oral liquid; PROCYSBI (cysteamine bitartrate) delayed-release capsules and granules for oral use; ACTIMMUNE (interferon gamma-1b) injection for subcutaneous use; BUPHENYL (sodium phenylbutyrate) tablets and powder for oral use; QUINSAIR (levofloxacin) solution for inhalation; and UPLIZNA (inebilizumab-cdon) injection for intravenous use. The company also markets PENNSAID (diclofenac sodium topical solution) for topical use; DUEXIS (ibuprofen/famotidine) tablets for oral use; RAYOS (prednisone) delayed-release tablets for oral use; and VIMOVO (naproxen/esomeprazole magnesium) delayed-release tablets for oral use. It has collaboration agreements with HemoShear Therapeutics, LLC.; Alpine Immune Sciences, Inc.; Halozyme Therapeutics, Inc.; and Arrowhead Pharmaceuticals, Inc. The company was formerly known as Horizon Pharma Public Limited Company and changed its name to Horizon Therapeutics Public Limited Company in May 2019. Horizon Therapeutics Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland with additional offices in Deerfield, Illinois; Chicago, Illinois; Lake Forest, Illinois; South San Francisco, California; Washington, D.C.; Gaithersburg, Maryland; Rockville, Maryland; and Mannheim, Germany.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Walbert Timothy PChairman, President and CEOMay 20Option Exercise22.1425,000553,500485,549May 20 06:15 PM
Walbert Timothy PChairman, President and CEOMay 20Sale90.0025,0002,250,000460,549May 20 06:15 PM
Walbert Timothy PChairman, President and CEOMay 11Option Exercise22.1417,600389,664478,149May 13 04:31 PM
Walbert Timothy PChairman, President and CEOMay 11Sale90.0017,6001,584,000460,549May 13 04:31 PM
Walbert Timothy PChairman, President and CEOMay 06Option Exercise22.147,400163,836467,949May 10 05:59 PM
Walbert Timothy PChairman, President and CEOMay 06Sale90.867,400672,342460,549May 10 05:59 PM
Walbert Timothy PChairman, President and CEOMay 02Sale96.0425,0002,401,006460,549May 04 04:24 PM
Walbert Timothy PChairman, President and CEOApr 22Option Exercise22.1425,000553,500510,549Apr 22 06:49 PM
Walbert Timothy PChairman, President and CEOApr 22Sale106.5925,0002,664,632485,549Apr 22 06:49 PM
Hoelscher Paul W.EVP, CFOApr 20Option Exercise22.1450,0001,107,00051,049Apr 22 06:47 PM
Hoelscher Paul W.EVP, CFOApr 20Sale114.7150,0005,735,4491,049Apr 22 06:47 PM
Thompson Elizabeth H.Z.EVP, Research & DevelopmentApr 18Sale115.648,098936,45313,058Apr 20 04:13 PM
DesJardin Michael A.EVP, Technical OperationsApr 12Sale113.1220,2142,286,70382,346Apr 14 04:49 PM
Walbert Timothy PChairman, President and CEOApr 08Option Exercise22.1425,000553,500510,549Apr 08 04:11 PM
Walbert Timothy PChairman, President and CEOApr 08Sale112.3825,0002,809,521485,549Apr 08 04:11 PM
Hoelscher Paul W.EVP, CFOApr 06Option Exercise21.27215,3354,580,417216,384Apr 08 04:09 PM
Hoelscher Paul W.EVP, CFOApr 06Sale110.0191,71010,089,02666,673Apr 08 04:09 PM
Hoelscher Paul W.EVP, CFOApr 06Sale110.01215,33523,688,7881,049Apr 08 04:09 PM
SHERMAN JEFFREY WEVP and Chief Medical OfficerApr 06Sale110.0242,0094,621,87210,629Apr 08 04:07 PM
Walbert Timothy PChairman, President and CEOMar 30Sale105.2650,0005,262,787485,549Apr 01 04:10 PM
Walbert Timothy PChairman, President and CEOMar 25Option Exercise22.1425,000553,500560,549Mar 25 06:40 PM
Walbert Timothy PChairman, President and CEOMar 25Sale109.3725,0002,734,340535,549Mar 25 06:40 PM
Hoelscher Paul W.EVP, CFOMar 25Sale110.0066372,930158,383Mar 25 06:38 PM
Hoelscher Paul W.EVP, CFOMar 24Sale110.001,481162,910159,046Mar 25 06:38 PM
Hoelscher Paul W.EVP, CFOMar 23Option Exercise15.9626,090416,39627,139Mar 25 06:38 PM
Hoelscher Paul W.EVP, CFOMar 23Sale110.0111,6991,287,018160,527Mar 25 06:38 PM
Hoelscher Paul W.EVP, CFOMar 23Sale110.0026,0902,870,0021,049Mar 25 06:38 PM
SHERMAN JEFFREY WEVP and Chief Medical OfficerMar 18Option Exercise22.148,531188,87652,638Mar 21 04:25 PM
Walbert Timothy PChairman, President and CEOMar 11Option Exercise22.1425,000553,500560,549Mar 11 05:17 PM
Walbert Timothy PChairman, President and CEOMar 11Sale100.9325,0002,523,314535,549Mar 11 05:17 PM
DesJardin Michael A.EVP, Technical OperationsMar 02Sale97.1935,0003,401,752102,560Mar 04 04:19 PM
Pasternak AndyEVP and Chief Business OfficerFeb 18Sale94.821,313124,49939,659Feb 18 04:42 PM
Walbert Timothy PChairman, President and CEOFeb 11Option Exercise22.1425,000553,500610,549Feb 11 04:16 PM
Walbert Timothy PChairman, President and CEOFeb 11Sale97.4125,0002,435,242585,549Feb 11 04:16 PM
Walbert Timothy PChairman, President and CEOFeb 01Option Exercise0.009,087044,690Feb 02 04:25 PM
Walbert Timothy PChairman, President and CEOJan 31Sale91.85100,0009,184,983585,549Jan 31 05:26 PM
Walbert Timothy PChairman, President and CEOJan 28Option Exercise22.1425,000553,500710,549Jan 31 05:26 PM
Walbert Timothy PChairman, President and CEOJan 28Sale90.0025,0002,250,000685,549Jan 31 05:26 PM
DesJardin Michael A.EVP, Technical OperationsJan 21Option Exercise0.003,6790139,385Jan 24 05:07 PM
Hoelscher Paul W.EVP, CFOJan 21Option Exercise0.005,558070,138Jan 24 05:06 PM
SHERMAN JEFFREY WEVP and Chief Medical OfficerJan 21Option Exercise0.005,354061,665Jan 24 05:05 PM
Walbert Timothy PChairman, President and CEOJan 21Option Exercise0.0020,3360694,558Jan 24 05:04 PM
Walbert Timothy PChairman, President and CEOJan 14Option Exercise22.1425,000553,500699,222Jan 14 06:44 PM
Walbert Timothy PChairman, President and CEOJan 14Sale90.0225,0002,250,412674,222Jan 14 06:44 PM
Pasternak AndyEVP and Chief Business OfficerJan 06Sale99.577,987795,29640,972Jan 06 09:02 PM
Walbert Timothy PChairman, President and CEODec 31Option Exercise22.1425,000553,500529,482Jan 04 05:00 PM
Walbert Timothy PChairman, President and CEODec 31Sale108.0775,0008,105,487454,482Jan 04 05:00 PM
Hoelscher Paul W.EVP, CFODec 28Option Exercise15.968,575136,8579,624Dec 30 09:00 PM
Hoelscher Paul W.EVP, CFODec 28Sale110.008,575943,2501,049Dec 30 09:00 PM
Pasternak AndyEVP and Chief Business OfficerDec 07Sale100.001,525152,50021,830Dec 08 06:35 PM
McHugh Miles WSr VP & Princ. Acctg OfficerDec 01Option Exercise22.1479,4841,759,776116,005Dec 03 05:20 PM
McHugh Miles WSr VP & Princ. Acctg OfficerDec 01Sale106.6279,4848,474,58436,521Dec 03 05:20 PM
Walbert Timothy PChairman, President and CEONov 30Sale102.4050,0005,119,881504,482Dec 01 05:58 PM
MOZE BARRYEVP, Chief Admin. OfficerNov 04Option Exercise14.7775,7431,118,556151,424Nov 05 05:00 PM
Pasternak AndyEVP and Chief Business OfficerNov 04Option Exercise29.5223,251686,37053,523Nov 05 05:00 PM
MOZE BARRYEVP, Chief Admin. OfficerNov 04Sale112.2875,7438,504,20875,681Nov 05 05:00 PM
Pasternak AndyEVP and Chief Business OfficerNov 04Sale113.0430,1683,410,18123,355Nov 05 05:00 PM
Walbert Timothy PChairman, President and CEONov 01Sale118.4925,0002,962,327554,482Nov 03 04:30 PM
SHERMAN JEFFREY WEVP and Chief Medical OfficerOct 27Option Exercise7.6110,72981,64819,844Oct 29 04:55 PM
Walbert Timothy PChairman, President and CEOSep 30Sale110.3050,0005,515,140579,482Oct 01 04:08 PM
SHERMAN JEFFREY WEVP and Chief Medical OfficerSep 21Option Exercise7.6146,271352,12255,386Sep 23 05:00 PM
SHERMAN JEFFREY WEVP and Chief Medical OfficerSep 21Sale110.0046,2715,089,8109,115Sep 23 05:00 PM
Beeler Brian KEVP, General CounselSep 17Sale107.9128,1433,036,91162,775Sep 17 05:06 PM
Pasternak AndyEVP and Chief Business OfficerSep 09Option Exercise29.5223,250686,34046,604Sep 13 08:00 PM
Pasternak AndyEVP and Chief Business OfficerSep 09Sale107.8423,2502,507,26123,354Sep 13 08:00 PM
Walbert Timothy PChairman, President and CEOAug 27Option Exercise22.147,435164,611847,723Aug 27 05:00 PM
Beeler Brian KEVP, General CounselAug 16Option Exercise22.1465,8571,458,074165,816Aug 17 05:01 PM
Beeler Brian KEVP, General CounselAug 16Sale106.0074,8987,939,18890,918Aug 17 05:01 PM
Thompson Elizabeth H.Z.EVP, Research & DevelopmentAug 05Sale106.347,542802,02514,187Aug 06 05:03 PM
Walbert Timothy PChairman, President and CEOJul 30Sale101.7425,0002,543,489840,288Jul 30 04:28 PM
GREY MICHAEL GDirectorJul 22Option Exercise2.375,00011,8505,000Jul 23 05:00 PM
GREY MICHAEL GDirectorJul 22Sale100.045,000500,2000Jul 23 05:00 PM
MOZE BARRYEVP, Chief Admin. OfficerJul 08Sale92.5435,0763,246,01271,639Jul 09 05:00 PM
Walbert Timothy PChairman, President and CEOJun 01Sale91.8525,0002,296,204875,887Jun 03 04:41 PM